Eosinophils and lung fibroblasts:activation, interaction and modulation by Spoelstra, Fopkje Minke
  
 University of Groningen
Eosinophils and lung fibroblasts
Spoelstra, Fopkje Minke
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2000
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Spoelstra, F. M. (2000). Eosinophils and lung fibroblasts: activation, interaction and modulation. Groningen:
s.n.
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
As outlined in the Introduction of this thesis, asthma is a disease characterized by a
distinct infiltration of eosinophils into the pulmonary tissue and airway lumen especially after
inhalation of allergen. The released mediators of activated eosinophils constitute a deleterious
effects such as tissue toxicity and bronchoconstriction, resulting in inflammation and tightness
of the chest. Not only do these inflammatory processes occur in bronchi, but also in small
airways I and even in lung parenchyma 2. Fibroblasts comprise the major cell type of the
interstitial lung tissue. These cells have shown to be able to play a role in inflammation
comparable to endothelial and epithelial cells, although they were initially supposed to be
exclusively involved in maintenance of tissue structure. Interactions between infiltrating
eosinophils and lung fibroblasts may contribute to the activation of eosinophils. Possible
interactions can be divided into adhesive interactions (cell-to-cell or cell-to-matrix) and soluble
factor-mediated interactions. Anti-inflammatory actions of drugs used in asthma therapy, such
as glucocorticoids and long-acting pr-agonists, may target on infiltrating inflammatory cells,
but also on resident pulmonary cells, decreasing the number of inflammatory cells in the lung
tissue, thereby preventing deleterious effects of e. g. degranulation.
Expression and modulation of adhesion molecules on lungfibroblasts
To assess the expression of ICAM-I and VCAM-I on lung fibroblasts, both important in
adhesion to leukocytes, we set up a Cell Surface ELISA (CSE) technique based on a method
used by Piela and coworkers 3. The advantage of this technique over the much-used FACS
analysis is, that it gives the opportunity to study these cells close to their 'in situ' situation and
it bypasses the necessity of dissociating the separate fibroblasts from the monolayer formed
under culture conditions. Therefore, it rules out the possibility of loss of adhesion molecules
from the cell surface during (enzymatic) dissociation. However, with CSE it is not possible to
measure expression on individual cells. This may obscure possible cell subsets within the
fibroblast population (i.e. myofibroblasts) with different expression and regulation patterns
concerning adhesion molecules. It is also difiicult to establish a good calibration with CSE; in
our system quantification ofexpression is only possible in relation to the expression on control
(unstimulated) cells.
We cultured lung fibroblasts in passage 5 from lung tissue samples by explant technique.
Small pieces of tissue were cultured in 12-wells culture plates in Ham's Fl2 medium, providing
limited interference. After a few days, mainly fibroblasts started growing out of the tissue,
because culturing epithelial, endothelial and smooth muscle cells requires special media in
order to supply dpecific growth factors. Approximately two weeks later, the wells were washed
and adhering cells were trypsinized and passaged to culture flasks. In this step it is thought hat
contaminating macrophages stay behind in the plate. Fibroblasts achieved growth advantage
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put in culture again and passaged for a total of 5 times, we found a purity of >95 oÁ.
Contaminating cells are mainly smooth muscle cells. In passage 5 fibroblasts are thought to
have still the same characteristics as ln vlvo, since differences between patient fibroblasts and
healthy control fibroblasts are still present in that passage number o. The more often they are
passaged, the more risk of changes in their phenotype. On the other hand, the number of 5
passages is necessary to multiply the number of cells needed to perform all experiments. In our
experiments we used confluent layers of fibroblasts, because we think them to be more potent
in production, than when they are still in an active growth phase and to exclude as best as
possible differences in cell number between different -wells. It is difficult to predict the
diflerences and similarities between lung fibroblasts and bronchial fibroblasts. Both types of
fibroblasts are used in research in the field of asthma, and both are from pulmonary origin. We
have chosen to use lung fibroblasts in our studies, because they were available to us in larger
quantities than bronchial fibroblasts, which was necessary for the large number of experiments
planned. A recent publication showing asthmatic inflammation in lung parenchyma and smaller
airways next to bronchial inflammation supports this choice.
The knowledge about factors increasing IC.dM-l and VCAM-I expression on human
lung fibroblasts is limited. In Chapter 2, we show that human lung fibroblasts increase both
ICAM-I and VCAM-I expression after IL-lp and TNFo, stimulation, whereas IFNI
specifically increases ICAM-I expression and lL-4 only increases VCAM-I expression. \ffe
also demonstrate that IL-5 does not affect ICAM-I or VCAM-I expression on human lung
fibroblasts, whereas TGFB decreases VCAM-1 expression, but only after longer incubation
times. The optimal time for ICAM-I expression was approximately 8 h after stimulation,
staying stable for at least 24 h. VCAM-I expression was transient, it reached an optimum
around 8 h, but decreased again within 24 h.
The differential effects of IFN1 and IL-4 are in accordance with results of other studies.
IFN'y increased ICAM-I expression on skin fibroblasts and endothelium 3'5, IL-4 increased
VCAM-I expression on endothelium, lung fibroblasts and skin fibroblasts 16. However, on skin
fibroblasts VCAM-I expression increased after IFNy 7 as well as ICAM-l expression after IL-
4 8 stimulation, an indication for fibroblast heterogeneity dependent on tissue origin. The fact
that ICAM-I expression is reaching a plateau in time after stimulation is in agreement with
expression on endothelial cells e. Recently, it was shown that TGFp inhibited VCAM-I
upregulation by TNFo and IL-4 on a bronchial epithelial cell line t0, which meets our results of
a decrease in VCAM-1 basal expression on lung fibroblasts. There is not much known about
the in vivo expression of adhesion molecules in the connective pulmonary tissue, but it is
known that the number of ICAM-l and VCAM-1 positive blood vessels in bronchial biopsies
are higher in asthma patients 11.
The upregulation of these adhesion molecules on endothelium and fibroblasts by
cytokines may add to increased infiltration of inflammatory cells in the pulmonary tissue as
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seen in asthma by binding to the corresponding adhesion molecules. Moreover, the selective
increase of VCAM-l on lung fibroblasts by the Th2 type cytokine IL-4 and the extended
expression may contribute to selective eosinophil transmigration through the pulmonary tissue
in a directional migration towards the epithelium The finding that fibroblasts possibly act as
important intermediate cells in the inflammatory response, places these cells in Íbcus Íbr
modulation by therapeutic regimens currently used in asthma.
ln a similar experimental setting, we show that the glucocorlicoid budesonide and the
long-acting B.-agonist formoterolboth inhibit lL-lP-, TNFU-, IFNl- and IL-4-induced ICA\Í-
L and VCAM-1 upregulation on human lung fibroblasts at therapeutical levels (Chapter3)
Moreover, we also Íbund a small reduction in basal ICAM- I and VCAM- 1 expression by both
drugs Glucocorticoids in general have an inhibit ing eftèct on ICAM- I upregulation on
endothelial r2 and epithelial cells r3. The only report so lar of p,-agonists inhibit ing ICAI\4-l
expression comes from Oddera and colleagues. who described the inhibit ion of lFNl-induced
ICAM-1 expression on bronchial epithelial cells by fenoterol ' t. For hudesonide, the smalle$
inhibit ing concentration of I 0-e M is considered to be therapeutical, since concentrations of I 0-e
M were found in blood and 10-" M in lung tissue However, this was after a single high dose ol
eight t imes the normal dose of budesonide As budesonide is inhaled regularly, we consider a
concentration of l0-'M at least present in lung tissue. For fbrmoterol there are less data on
concentrations achieved in vivo. But inhalation of a six times normal dose l, ielded 2 5 'r '  l0-r"Il
in plasma, from which it can be assumed that the concentration in tissue wil l probably reach 2.-s
*  l o - e M  r 5 .
We conclude that the beneÍlcial eÍïect of inhaled budesonide as well as inhaled
formoterol in asthma can be due to the modulation of the expression of adhesion moleculeson
resident cells, e.g. f ibroblasts in lung tissue, thus diminishing infi l tration and/or retention o1'
inflammatory cells.
Most asthmatic patients regularly use both glucocorticoids and long-acting p,-agonists al
the same time Litt le is known about the possible interactions between these drugs. Possible
deleterious effects irt ttilro have been described Íbr short-acting B,-agonists by counteractrng
the anti-inflammatory properties of glucocorticoids on eosinophils 'o On the other hand. a
clinical study (FACET) using formoterol in addition to budesonide, showed beneficial eftècts
on asthma symptoms, exacerbation frequency and lung lirnctionIt This may be a result ol
additive anti-inflammatory efïects in the lung Therefore, we studied the eftèct of the
combination of formoterol and budesonide on ICAM-1, VCAM-1 upregulation and GM-CSF.
IL-8 production of human lung Íibroblasts after lL-lB stimulation (Chapter 4) Budesonide
and formoterol alone both inhibited GM-CSF production of human lung Íibroblasts. However.
formoterol alone did not inhibit IL-lB-induced IL-8 production, whereas budesonide did We
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upregulation and GM-CSF production by budesonide, but not on inhibition of IL-S production.
This reflects the inhibitory capacity of formoterol alone. The additive effect of formoterol was
not dependent on the sequence in which the drugs were added. This is in contrast to the results
of Korn and coworkers, who described an inhibitory effect of the Br-agonist terbutaline on the
regulation of glucocorticoid receptor mRNA expression by budesonide in epithelial cells. This
was only the case when these drugs were administered simultaneously, but not when
budesonide was added 4 h before terbutaline tt. The explanation for this can be found in the
molecular mechanisms underlying the effect of these drugs. Glucocorticoids cross the lipid
bilayer cell membrane and bind to the GR in the cytoplasm forming a complex. After
translocation to the nucleus, the complex can bind to GRE in the promoter regions of certain
genes, influencing their transcription. The complex can also scavenge transcription factors in
the cytoplasm, thereby preventing translocation and activity of these factors. pr-agonists are
thought to act by means of p-adrenoceptor binding, leading to cAMP production in the cell.
This leads to activation of the transcription factor CREB (cAMP responsive element binding
protein), that can bind to specific sequences in promoter regions of certain genes. CREB is
able to interact with other transcription factors as well as the GR-GC complex. This may affect
gene transcription (stimulation or inhibition). Possible interactions when glucocorticoids and
Br-agonists are added in the same system can be both negative and positive.
We found no reason at the level of the human lung fibroblast activation not to use these
drugs simultaneously. On the contrary, beneficial effects as have been established in i.e. the
FACET study r7 may partially have been achieved through additive inhibition of cellular
infiltration, due to diminished adhesion molecule expression and GM-CSF production of lung
fibroblasts by budesonide and formoterol.
Activalion and modulation of activqtion of eosinophils
In order to study interactions of specific cell types, it is necessary to puri$ the desired
cells, in order to exclude possible interactions with contaminating cells during culture. For
isolation of eosinophils from peripheral blood we used the MACS technique. First, neutrophils
and eosinophils were separated from other leukocytes by centrifugation over Percoll (density
1,082 g/ml). After lysis of erythrocytes, neutrophils were removed with anti-CDl6 antibodies
linked to microscopically small magnetic beads in a magnetic field. Eosinophils were eluted
untouched, with high purity and high recovery 1e. It was demonstrated that this method yields a
more active and more complete population of eosinophils (fairer representation of all
eosinophils present in blood)" than previous isolation methods using fIVILP stimulation and
centrifugation over Percoll, where the most active eosinophils are lost 20.
The influence ofisolation on eosinophil behaviour cannot totally be prevented. From our
experiments it was clear that isolated eosinophils had higher CDllb expression and lower L-
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selectin expression, variables that indicate activation, than whole blood eosinophils. However,
after culture the CDi 1b level decreased again, possibly indicating a Íeturn to the resting state
Eosinophils in BAL of asthmatic patients after allergen challenge display an activated
phenotype They release more degranulation products and metabolites than blood eosinophils
and express high CDllb levels and low L-selectin levels 2r In our studies, we used the two
latter characteristics as variables of eosinophil activation. Upregulation of CDllb can occur
through mobil izing molecules from specific granules (minutes) or de nrtvo synthesis (hours) L-
selectin is shed from the surface through activation of an enzyme cleaving the molecule
Eosinophils are probably activated during migration through the lung tissue. On their way to
the airway lumen, eosinophils encounter activated tissue cells, such as endothelial cells,
f ibroblasts, smooth muscle cells and epithelial cells From coculture studies of endothelium or
epithelium with eosinophils, it became clear that these cells were able to contribute to
eosinophil activation 2r'23. We cocultured eosinophils derived from peripheral bloocl o1'
nonatopic controls with lung fibroblast cultures of a nonasthmatic ontrol, with or rvithout lL-
1B preincubation to rnimic the inflamed state of the asthmatic lung.
Our results in Chapter 5 show that human lung fibroblasts from normal individuals are
able to activate isolated peripheral eosinophils from nonatopic individuals in vitro as
dernonstrated by increased CDllb expression and decreased L-selectin expression of
eosinophils as well an increased viabil ity Activating effects on eosinophils were more
pronounced when fibroblasts had been in contact with the proinflammatory cyokine IL.-lB
GM-CSF produced by fibroblasts appeared to be the most imporlant factor in eosinophil
activation, because addition of neutralizing anti GM-CSF antibody nearly totally abrogated
CDllb upregulation and L-selectin shedding. Only in the case of CDllb upregulation an
influence of direct eosinophil-f ibroblast contact could not be excluded. GM-CSF is known to
increase CDI1b expression on eosinophils ", but L-selectin shedding is controversial rjr ' '
Furthermore, viabil ity of eosinophils is increased when cultured with GM-CSF 27, which can be
ascribed to inhibit ion of the apoptotic programming of the cell. However, in our study,
addition of anti GM-CSF only parrly inhibited eosinophil survival under some, but not all
circumstances, suggesting that other factors are involved Furthermore, fibroblasts
preincubated with lL-lp and subsequently multiplying their GM-CSF release, did not
significantly increase osinophil viabil ity compared to unstimulated Ílbroblasts This indicates a
different mechanism for enhancement of eosinophil survival by frbroblasts. In comparable
studies of eosinophil survival by fibroblasts, GM-CSF w.as also found to be only partly
responsible for increased viability t'''n. ln contrast to the findings with fibroblasts, GM-CSF
produced by epiihelial cells was totally responsible for the increased eosinophil viabil ity r0 The
knowledge that human lung fibroblasts from normal individuals are able to activate eosinophils
may have important implications for the understanding of the pathogenesis of asthma







































o the resting state
jisplay an activated
n b lood eosinophi ls
s, we used thc two
I  CDl  lb  can occur
ynthesis (hours) L-
vrng the molecr,rle
e.  On thei r  way to
;  endothel ia l  ce l ls ,
rof  endothel iurn or
: to contribute tct
:ripheral blood oÍ'
, , r i th  or  wi thout  I I - -
nal  ind iv iduals are
duals llr t,ilnt as
tin expression ctÍ '
rphils were nrore




-CSF is  known ro
controversial r5 rt '
F 27, which can bc
'er, rn our study,
some, but not all
rore, Í lbroblast s
release, did not
;  This  indicatcs a
s. In comparablc
o be only partly
rb lasts,  GM-CSl i
i l  viabil ity r,) l-hc
i ivate eosinophi ls
res is  of  asthma
inophil-Írbroblasr
contact and interaction, in addition to interactions with endothelir-rn.r and epithelium. Fibroblasts
thus nray contribute to the activation of eosinophils as observed in pulmonary biopsies and
BAL
A benellcial el}èct of budesonide as \À'ell as lbrmoterol in asthma therapy is inhibit ion of
eosinophil inÍl l tration in the air-way wall and eosinophil activation ' '  To determine whether
cosinophil activation induced by Írbroblast-conditioned rnedium (after lL-1B stimulation) and
measulcd by rlodulation of CDllb and L,-selectin expression can be inhibited by budesonide
and Íbrmoterol. rve incubatcd lung flbroblasts with budesonide and/or Íbrmoterol and collected
conditioned rnedium afterwards (Chaptcr 6) Thc obtained dil l 'erent conditioned media were
incubated with eosinophils and their activation state deterrnined We considered this to be an
indirect inhibit ion o1' eosinophil activation, because the target cells Íbr drug effects were
tlbroblasts. ln the other case, we incubated eosinophils with conditioned medium of Í lbroblasts
unmodulated by drugs, and added budesonide and/or formoterol to the eosinophil cultures. Wc
consiclered this to be a direct inhibit ion oleosinophil activation, because in this case the target
cells fbr drug eÍïects were eosinophils We founcl that eosinophil activation after frbroblast-
conditioned nredium cxposure is inhibited indirectly (through modulation of Í ibroblasts) by
budesonide and Íbrmoterol, probably through decreased GM-CSF production. Direct inhibit ion
(through modulation of eosinophils) is much less clear and observed only on eosinophils after
l6 h of incubation with budesonide, but not after 4 h Formotcrol did not inhibit eosinophil
activation drrectly at all t irne points tbr either CDllb upregulation and L-selectin shedding.
This finding is opposite to the eÍÏect of another B.-agonist, isoproterenol, that was able to
inhibit eosinophil CDllb upregulation directly (Chapter 7). In contrast to effects on adhesion
rnolecules, tbrn.roterol inhibited PAF-induced guinea piS eosinophil chemotaxis and
degrantr la t ion at  h ish concentrat ions r l
ln our study lve did not f ind an additive e1Èct of the combination of budesonide and
fbrmotcrol on eosinophil activation, in contrast to the results on Ílbroblasts described in
Chapter 4 This is probably due to diÍïèrent mechanisms involved in eosinophil activation
compared to Ílbroblast activation. We conclude that resident cells in the lungs, such as
flbroblasts, may be an important target cell for anti-inÍ' lammatory effects induced itr vivo by
budesonide as well as fornroterol, eventually leading to less infi l tration and activation of
inflamrnatory cells, sr.rch as eosinophils
In the theophyll ine study (Chapter 7), we have chosen to use whole blood eosinophils,
omitting isolation steps Incubation with theophyll ine was performed in whole blood samples,
therebl' keeping close to the lrr l l lo situation and preventing possible activation of
granulocytes by isolation ploe edules tr This was possible because incubation times were only
i0 minutes, rcducing the chance of interlerence with other cell types
( ienc ra I di.sctt.s.t ion unc/ conc lus Í on 143
An inhibitory effect on the PAF-induced density shift of eosinophils and neutrophils in
whole blood samples was observed with theophyll ine (l0rM). Furthermore, it was shown that
in a near-therapeutic oncentration (104M). theophyll ine signifrcantly inhibited the PAF-
induced modulation of CDl lb and L-selectin expression on eosinophils and neutrophils lr
vllro. Normally, serum concentrations of approximately 9 mg/ml equivalent to 0.5*10-r M are
found sa It is possible that locally in the tissue higher concentrations are reached In our
experiments a concentration of l0-s M theophyll ine did not have a significant eftèct. but in
another study with minor differences in design, this therapeutic concentration did shon'
s igni f icant  inh ib i tory eí Iects r '
The p-agonist isoproterenol is able to exert an additive inhibitory eÍIect on the
modulation of CDllb and L-selectin expression in combination with theophyll ine A weak
synergistic eÍIect was observed in some circumstances The additional efïèct is probably due to
the fact that both substances increase intracellular cAMP levels, but use different pathwaysrórt
There r.vere no significant differences between healthy controls and asthmatic patients with or
without corticosteroid treatment in the inhibitory eÍïect of theophylline on the PAF-induced
density shift in eosinophil and neutrophil populations, or in the CDI lb and L-selectin
expression on neutrophils. However, diÍïerences were found between the subject groups in
eosinophil CD I 1b and L-selectin expression after theophylfine incubation. The hrgher
inhibitory percentages in our patient groups could be due to higher PDE activity in PBMC o1'
allergic patients as was described by Barnes 3t The attenuation of CDllb and L-selectin
expression on eosinophils by theophyll ine may have implications for the adhesion to
endothelium and transendothelial migration of granulocytes in inflammatory tissues in patients
with asthma, but the rather high levels needed to observe efïects must be kept in mind.
CONCLUDING REMARKS
From our studies it can be concluded that
1 Inflammatory cytokines involved in asthma are able to modulate adhesion molecule
expression on human lung fibroblasts. Proinflarnmatory cytokines IL-lB and TNFa,
present in most inflammatory processes, increase the expression of both ICAM-l and
VCAM-I The Th2 type cytokine lL-4 exclusively increases VCAM-I expression,
whereas the Thl type cy'tokine IFN'y only increases ICAM-l expression. Furthermore,
TGFB, a cyokine associated with fibroblast proliferation, ECM production and
differentiation of fibroblasts into myoÍibroblasts appears to decrease VCAM-l expression
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The glucocorticoid budesonide and the long-acting p,-agonist formoterol, both used as
inhaled drugs in asthma therapy, inhibit the increase in ICAM-l and VCAM-i expression
on hunran lung Íibroblasts induced by aÍorementioned cytokines in viÍr 'o.ln the clinically
relevant concentration of l0-' '  M the increase in adhesion molecule expression can be
inhibited by minrmally 30 % (Chapter 3) Budesonide inhibits GM-CSF and lL-S
production, whereas fbrmoterol only inhibits GM-CSF production by lung fibroblasts
The combination of budesonide and formoterol, as they are often prescribed in asthma
therapy, shows an additive etïèct on inhibit ion of adhesion molecule expression and GM-
CSF production (Chapter 4)
Human lung Íibroblasts aÍe able to activate eosinophils under coculture conditions.
eosinophils how increased expression of CDllb and decreased expression of L-selectin.
The activating eflect is largely due to GM-CSF production by Íibroblasts, although
efïects ofdirect interactions could not be entirely excluded (Chapter 5)
Budesonide has a direct inhibitory efïèct on CDllb and L-selectin modulation on
eosinophils, in contrast o lbrmoterol (Chapter 6) The inhibitory capacity of budesonide
and lbrmoterol is laster c.q stronger on fibroblasts compared with the direct effects on
eosinophils Budesonide and formoterol inhibit f ibroblast release of eosinophil activating
products, which results in less eosinophil CDllb upregulation and L-selectin shedding
when cultured in fibroblast-conditioned medium, probably due to less GM-CSF
production Theophyll ine is able to inhibit CDl1b upregulation and L-selectin shedding
of eosinophils stimulated with PAF. In higher concentrations it also prevents the
development of hypodense osinophils (Chapter 7)
ln summary. human lung fibroblasts can be involved in asthma by providing factors to
activate eosinophils and expressing adhesion molecules (ICAM-1, VCAM-l) They appear to
be more sensitive to inhibitory drugs compared with eosinophils and therefore may be
irnportant targets Íbr anti-inÍlamnratory drugs used in asthma therapy
FUTT]RE PERSPECTIVES
Until now, the role of f ibroblasts in asthma has been underexposed. Lately, there has
srou'n increasing intcrest in fibroblasts as ECM-producing cells, contributing to basal
membrane thickening as occuÍs in asthma. The production of growth factors by fibroblasts can
also be crucial in this process The research on bi-directional interaction of (myo)fibroblasts
and epithelial cells (as a reaction on epithelial injury) is developing and enlarges insight in
remodell ing processes Our studies stress that new perspectives of research should focus more
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on fibroblasts. Next to its role in airway remodelling, the fibroblast is also able to mediate
inflammatory processes. The cell expresses the adhesion molecules ICAM-l and VCAM-1,
thereby providing binding to infiltrating inflammatory cells. A number of inflammatorv
cytokines can be produced by fibroblasts as well
In future research, fibroblasts derived from small airways, parenchyma and bronchi of
asthmatic patients and controls should be compared concerning their characteristics of
adhesion molecule expression and cy'tokine production after difïèrent stimuli. Intrinsic
differences may be detected, provided that passage numbers are not too high It is best to keep
as close as possible to the fu r,lvo situation of the cells and compare them in primary cultures tcr
be reasonably sure ofan unchanged phenotype
Research on interaction of pulmonary Íibroblasts with inflammatory cells should be
extended Eosinophil adhesion to fibroblasts, and more importantly, eosinophil transmigration
over fibroblast layers or preferably a 3D ECM gel with fibroblasts in it (with or without
adjacent endothelium and epithelium), has not been fully investigated yet. The involvement of
putative adhesion molecules should be elucidated. The combination of 'asthmatic' f ibroblasts
with 'asthmatic' eosinophils, 'asthmatic' Íibroblasts with normal eosinophils and vice verso,as
well as normal fibroblasts with normal eosinophils can possibly further elucidate the role of
fibroblasts in asthma and mechanisms of interaction that may be divergent in asthma. The same
applies for fibroblast interaction with other infiltrating cells, such as lymphocytes, monocytes
and neutrophils derived from normal, asthmatic and perhaps allergic subjects. This knowledge
may be important in the development of new and more effective treatments or prevention of
asthma.
Eosinophil infiltration is sometimes also observed in chronic obstructive pulmonary
disease (COPD) Therefore, eosinophils could play a role in the process of COPD as well and
it would be interesting to learn rnore about the interaction between eosinophils and lung
fibroblasts from COPD patients
Recently, it has been demonstrated that epithelial cells are able to respond directly with
an inflammatory reaction 0L-6, IL-8 production) after contact with certain toxic particles and
allergen components (such as diesel exhaust particles, Der pl and Aspergillus flmigcrtu.t
proteases). At the moment, we do not know yet whether these substances are able to cross the
damaged epithelial barrier or basal membrane. However, it would be interesting to know,
whether these particles are also able to eiicit an inflammatory response from fibroblasts upon
contact.
In humans, pathological examination of airway and lung biopsies should be extended to
elucidate the role fibroblasts play in subepithelial fibrosis seen in asthmatic patients, possibly in
relation to infilirated eosinophils. Furthermore, the activity of lung fibroblasts in t,ito tn
different severities of asthma or after allergen challenge should be studied by parameters uch
as a.o. cyokine expression and adhesion molecule expression
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until now, animar models have only succeeded in mimicking temporary asthmaticfeatures' while chronic asthma as observed in humans is difficult to initiate in the existing
animal models The benefit of such a chronic model is the possibility to study the development
and progression of airway remodelling. In humans, it would be too aggravating to take biopsiesfor longitudinal research and results would become available after considerable time, while thetime of onset might be missed.
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